Starlinks Pharma Private Limited

Starlinks Pharma Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN U51909GJ2017PTC136596 Incorporated 19 May 2017 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹83.09 Lakh
▼ 8% YoY
Net profit · FY 2023
₹1.43 Lakh
Net margin 1.7%
EBITDA · FY 2023
₹1.78 Lakh
EBITDA margin 2.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings

About Starlinks Pharma Private Limited

Data last updated:

Starlinks Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2017PTC136596. Its GSTIN is 24AAYCS6842F1ZU (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It was formerly known as Stay Pharma Private Limited. It is led by directors Sampa Debabrata Saha and Debabrata Santosh Saha.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C 15/16 Krishna Industrial Estate Bidc Gorwa, Vadodara, Gujarat, India – 390023.

As per the financials filed for FY 2023, the company reported a revenue of ₹83.09 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.43 Lakh (net margin 1.7%) and EBITDA of ₹1.78 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 27% over five years.

As per MCA filings, the company has open charges of ₹50 Lakh on record.

Starlinks Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0003449). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909GJ2017PTC136596
Registration Number 136596
Incorporation Date 19 May 2017
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0003449

CIN history

Starlinks Pharma has one previous CIN (Corporate Identification Number): U51909WB2017PTC221048. The current CIN is U51909GJ2017PTC136596, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51909GJ2017PTC136596Current
U51909WB2017PTC221048Previous

Recognitions & Rankings of Starlinks Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-24-0003449

Contact details

Starlinks Pharma Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C 15/16 Krishna Industrial Estate Bidc Gorwa, Vadodara, Gujarat, India – 390023
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Starlinks Pharma Private Limited, buy the company report.

Comprehensive company report
Starlinks Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Starlinks Pharma Private Limited

FY 2024 filings available

Starlinks Pharma Private Limited reported revenue of ₹83.09 Lakh (down 8% YoY) for FY 2023.

Revenue · FY 2023
₹83.09 Lakh ▼ 8%
Net profit · FY 2023
₹1.43 Lakh margin 1.7%
EBITDA · FY 2023
₹1.78 Lakh margin 2.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 1%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▼ 50%
3 years · compounded
▼ 34%

Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹83.09 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.78 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.43 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin2.1%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Starlinks Pharma Private Limited, buy the company report.

Board of directors of Starlinks Pharma Private Limited

Starlinks Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sampa Debabrata SahaDirector19 May 20179 Years 5 MonthsCurrent
Debabrata Santosh SahaDirector19 May 20179 Years 5 MonthsCurrent

Auditor

Starlinks Pharma Private Limited is audited by MANDOWARA LADDHA & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MANDOWARA LADDHA & ASSOCIATESFY 2023127869W

Shareholding

The shareholding of Starlinks Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Starlinks Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Apr 2025101072216Others₹50 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Starlinks Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Starlinks Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AAYCS6842F1ZUGujaratActive01 Jul 2017
19AAYCS6842F1ZLWest BengalActive07 Jul 2017

To see the full GST registrations and return filing status of Starlinks Pharma Private Limited, buy the company report.

Recent activity

Starlinks Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Manav Saha ceased to be Director on 01 Jun 2024.

Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101072216 was registered on 02 Apr 2025.
AGM
Starlinks Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Manav Saha ceased to be Director.
Filing
Starlinks Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Appointed
Debabrata Santosh Saha was appointed as Director.
Appointed
Sampa Debabrata Saha was appointed as Director.
Incorporation
19 May 2017
Starlinks Pharma Private Limited was registered on 19 May 2017 with Roc Ahmedabad & aged 9 years 5 months as per MCA records.

Frequently asked questions

Starlinks Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2017 (9+ years old) and is registered under CIN U51909GJ2017PTC136596.

Starlinks Pharma has 2 current directors:

The latest financial statements of Starlinks Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Starlinks Pharma is 24AAYCS6842F1ZU, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 19AAYCS6842F1ZL (West Bengal).

The CIN (Corporate Identification Number) of Starlinks Pharma is U51909GJ2017PTC136596. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Starlinks Pharma was incorporated on 19 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Manav Saha ceased to be Director on 01 Jun 2024. Debabrata Santosh Saha was appointed as Director on 19 May 2017. Sampa Debabrata Saha was appointed as Director on 19 May 2017.

Yes, Starlinks Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0003449).

The registered office of Starlinks Pharma is at C 1516 Krishna Industrial Estate Bidc Gorwa, Vadodara, Gujarat, India – 390023.

Starlinks Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.